Novel PAradigm to Improve Inflammatory Burden in ESRD (rePAIR): A Pilot and Feasibility Randomized Controlled Trial (rePAIR)
Pilot and Feasibility Clinical Research Grants in Kidney or Urologic Diseases (R21)
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Listed as NCT03241511, this NA trial focuses on Chronic Periodontitis and End Stage Renal Disease and remains completed. Sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jul 2025 — Present [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2024 — Jul 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Mar 2021 — Feb 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2018 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
-
Sep 2017 — Oct 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- UConn Health
For direct contact, visit the study record on ClinicalTrials.gov .